CR9269A - Vacunas orales para peces - Google Patents

Vacunas orales para peces

Info

Publication number
CR9269A
CR9269A CR9269A CR9269A CR9269A CR 9269 A CR9269 A CR 9269A CR 9269 A CR9269 A CR 9269A CR 9269 A CR9269 A CR 9269A CR 9269 A CR9269 A CR 9269A
Authority
CR
Costa Rica
Prior art keywords
fish
production
complexes
protein complex
vaccines
Prior art date
Application number
CR9269A
Other languages
English (en)
Inventor
Elisabeth Antonius Florack Dionisius
Jan Bosch Hendrik
Original Assignee
Wageningen Business Generator B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wageningen Business Generator B V filed Critical Wageningen Business Generator B V
Publication of CR9269A publication Critical patent/CR9269A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion tiene que ver con el desarrollo, composicion y produccion de vacunas para las mucosas loralesi de los peces. De forma mas especifica, la invencion es relativa a complejos proteinicos que transportan antigenos a y a traves de las superficies mucosas de los peces para inducir una respuesta inmunitaria, y a la produccion de dichos complejos en una celula hospedadora, preferiblemente vegetal. Se provee el uso de un complejo proteinico que contiene un antigeno de interes fusionado con la subunidad B de la toxina del colera Vibrio cho]erae (CT-B) o de la enterotoxina termolabil Escherichia coli (LT-B) para la fabricacion de una vacuna oral para peces. Se provee tambien alimento para peces que contiene un complejo proteinico de la invencion.
CR9269A 2005-01-26 2007-07-20 Vacunas orales para peces CR9269A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05075203A EP1685848A1 (en) 2005-01-26 2005-01-26 Oral vaccines for fish

Publications (1)

Publication Number Publication Date
CR9269A true CR9269A (es) 2007-11-23

Family

ID=34938018

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9269A CR9269A (es) 2005-01-26 2007-07-20 Vacunas orales para peces

Country Status (8)

Country Link
US (1) US20080274126A1 (es)
EP (2) EP1685848A1 (es)
JP (1) JP2008531478A (es)
AU (1) AU2006209101A1 (es)
CA (1) CA2595913A1 (es)
CR (1) CR9269A (es)
NO (1) NO20074090L (es)
WO (1) WO2006080842A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010050586A1 (ja) * 2008-10-31 2010-05-06 ディナベック株式会社 組み換え蛋白質の発現を増強する方法
EP2412721A4 (en) * 2009-03-26 2012-08-29 Univ Tokyo Nat Univ Corp ANTI-KHV ANTIBODIES (KOÏ HERPESVIRUS) AND ANTIGEN ASSOCIATED
CL2009001197A1 (es) * 2009-05-15 2009-08-21 Farm En Aquacultura Veterinaria Fav S A Composicion farmaceutica veterinaria que contiene la variedad chilena del virus de la anemia infecciosa del salmon, marcadores proteicos y excipientes farmaceuticasmente aceptables; procedimiento de obtencion del virus; uso de la composicion para preparar una vacuna destinada a la prevencion del virus isa.
US8999319B2 (en) * 2010-06-09 2015-04-07 Mississippi State University Oral vaccination of fish with live attenuated Edwardsiella ictaluri vaccines
US9345760B2 (en) 2011-09-09 2016-05-24 Advanced Bionutrition Corporation IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same
CN107056898A (zh) * 2017-02-13 2017-08-18 中国水产科学研究院珠江水产研究所 鲤疱疹病毒3型1301株orf136基因重组表达蛋白、抗体及其应用
CN110747219A (zh) * 2019-11-29 2020-02-04 浙江省淡水水产研究所 一种可添加于饲料中的鲤鱼鲤春病毒血症口服疫苗
EP4110385A4 (en) * 2020-02-25 2024-10-02 Migal Galilee Research Institute Ltd. COMPOSITIONS COMPRISING ANTIGENS FOR LTB AND PATHOGENIC ANTIGENS AND THEIR USE
CN113951183B (zh) * 2021-11-19 2022-10-25 莱州明波水产有限公司 黄带拟鲹亲鱼培育方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354555A (en) * 1985-04-10 1994-10-11 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine to control the viral infection of fish
GB9112553D0 (en) * 1991-06-11 1991-07-31 Wellcome Found Fusion proteins
MX9703017A (es) * 1994-10-24 1997-10-31 Texas A & M Univ Sys Inmunizacion oral con plantas transgenicas.
WO1999018225A1 (en) * 1997-10-07 1999-04-15 Loma Linda University Expression of cholera toxin b subunit in transgenic plants and efficacy thereof in oral vaccines
CA2398462A1 (en) * 2000-01-27 2001-08-02 William H. R. Langridge Transgenic plant-based vaccines
EP1522585A1 (en) * 2003-10-09 2005-04-13 Plant Research International B.V. Chimeric carrier molecules for the production of mucosal vaccines

Also Published As

Publication number Publication date
EP1685848A1 (en) 2006-08-02
WO2006080842A2 (en) 2006-08-03
NO20074090L (no) 2007-10-24
AU2006209101A1 (en) 2006-08-03
EP1850868A2 (en) 2007-11-07
WO2006080842A3 (en) 2006-09-14
CA2595913A1 (en) 2006-08-03
JP2008531478A (ja) 2008-08-14
US20080274126A1 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
CR9269A (es) Vacunas orales para peces
CY1118492T1 (el) Φαρμακοτεχνικες μορφες εμβολιου norovirus
AR130402A2 (es) Formulaciones de anticuerpos anti-pdl1
CY1123450T1 (el) Μεθοδος καθαρισμου συζευγματων βασει il-15/il-15ra
MX2021000193A (es) Selección de epítopos de vacunas personalizadas contra el cáncer.
CY1117963T1 (el) Αντισωματα που προσδενουν τα il-17a και il-17f
CO2018005229A2 (es) Vacuna de virus sincitial respiratorio
CO6491045A2 (es) Composiciones de proteina f de virus sincitial respiratorio (rsv) y metodos para producir las mismas
AR088693A1 (es) Anticuerpos especificos para trop-2 y sus usos
UY37279A (es) Anticuerpos tgf-beta y fragmentos de unión de los mismos
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
EA201070200A1 (ru) Композиции, содержащие пневмококковые антигены
AR082149A1 (es) Anticuerpos contra el virus sincicial respiratorio (rsv) humano y metodos para su uso
PE20212265A1 (es) Bioconjugados de antigenos-polisacaridos de e. coli, metodos de produccion y metodos de utilizacion de los mismos
MX2016010954A (es) Construcciones de proteina superficial ubicua a2 y usos de las mismas.
WO2014150822A3 (en) Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
MX2009005414A (es) Formulaciones liquidas de anticuerpo antirrabico.
EA201891124A2 (ru) Новые мукозные адъюванты и системы доставки
BRPI0915076A2 (pt) composições de vacina, composição imunogênica, método para expressão dos antígenos quiméricos de hpv-hbsag supramencionados, composição farmacêutica, método para ocasionar resposta de anticorpo protetor para composição antigênica e/ou resposta de célula t citotóxica, uso das formulações antigênicas supramencionadas.
BRPI0621181A8 (pt) Substâncias imunogênicas que compreendem um adjuvante a base de ácido poliinosínico - ácido policitidílico
PE20180463A1 (es) Virus de la enteritis del pato y usos del mismo
BR112014020025A2 (pt) vacinas de subunidade de rotavirus e métodos de produção e uso das mesmas
TW200833709A (en) Archaeal polar lipid aggregates for administration to animals
CY1125328T1 (el) Ανασυνδυασμενο εμβολιο ιου λευχαιμιας αιλουροειδων περιεχοντας βελτιστοποιημενο γονιδιο φακελου ιου λευχαιμιας αιλουροειδων
CU23544A1 (es) Antígenos vacunales quiméricos contra el virus de la peste porcina clásica

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)